Overview

Aripiprazole Treatment of Prodromal Patients

Status:
Completed

Trial end date:
2007-02-01

Target enrollment:

Participant gender:

Summary

We hypothesize that symptoms will improve in patients who meet diagnostic criteria for the schizophrenia prodrome when they are prescribed aripiprazole.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Yale University

Collaborator:

Bristol-Myers Squibb

Treatments:

Aripiprazole